Maximize Market Research, a leading “Healthcare” business consultancy and research firm has published a report on the “Advanced Therapy Medicinal Products Market”. The total market opportunity for the Advanced Therapy Medicinal Products Market was USD 12.96 Bn. in 2023 and is expected to grow at a CAGR of 13.2 percent through the forecast period, reaching USD 30.87 Bn. by 2030. As per the report, the global Advanced Therapy Medicinal Products Market is expected to be dominated by the North America region to grow at a significant growth rate during the forecast period.
Market Size in 2021 USD 12.96 Bn.
Market Size in 2029 USD 30.87 Bn.
CAGR 13.2 percent (2024-2030)
Forecast Period 2024-2030
Base Year 2023
Number of Pages 189
No. of Tables 115
No. of Charts and Figures 125
Segment Covered Therapy Type, Disease Type, and Distribution Channel
Regional Scope North America, Europe, Asia Pacific, Middle East and Africa, South America
Report Coverage Market Share, Size & Forecast by Revenue | 2024-2030, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, MMR Competition Matrix, Competitive Leadership Mapping, Global Key Players’ Market Ranking Analysi
Get a free sample copy to fully comprehend the format of the report, which includes the table of contents and summary:https://www.maximizemarketresearch.com/request-sample/119588
Advanced Therapy Medicinal Products Market Scope and Research Methodology
The report on the Advanced Therapy Medicinal Products Market provides a thorough analysis of the market structure and the nature of competition in the market. The Advanced Therapy Medicinal Products Market size was estimated meticulously by using a bottom-up approach to get an understanding of the market growth. Key insights covered in the report include the major drivers of the market at the global and regional level, challenges for future growth and various opportunities in the market.
Regional analysis is conducted to provide information on the market leaders in various regions, market penetration and demographic factors affecting the regional Advanced Therapy Medicinal Products industry. For the competitive analysis of the Advanced Therapy Medicinal Products Market, a competitive matrix is made covering market leaders and new entrants. The report presents an overview of each company along with important takeaways based on the revenue generated, financial health, technological advancements, recent developments, mergers and acquisitions, joint ventures, alliances and marketing tactics.
The report also covers a strategic study of key market players in the market. The Advanced Therapy Medicinal Products Market report presents the key player’s in-depth analysis of the industry, including company profile, revenue, product specifications, technology development and product sales, price, and gross margin sales. The market overview of the industry and market development of Advanced Therapy Medicinal Products is given in the report. The SWOT analysis was used to study the strengths and weaknesses of the Advanced Therapy Medicinal Products Market.
Advanced Therapy Medicinal Products Market Overview
The Advanced Therapy Medicinal Products industry presents an appealing prospect for biotechnology and increased investment in research and development. By continuing agreement with the evolving pharmaceutical industry and growing trials pipelines involved significant growth in the market.
Advanced Therapy Medicinal Products Market Dynamics
Tissue engineering has greatly benefited in recent years from technological development. The rising clinical trials for advanced therapy medicinal products and the increasing awareness among researchers about the benefits of advanced therapies and driving the advanced therapy medicinal products (ATMP) market growth. The fluctuating prices of raw materials due to the unpredictable material/formulation changes pose a challenge to the global Advanced Therapy Medicinal Products industry’s growth. The market growth is also expected to be restrained by the availability of substitutes for Advanced Therapy Medicinal Products in the forecast period.
Advanced Therapy Medicinal Products Market Regional Insights
In North America, the Advanced Therapy Medicinal Products Market is expected to grow over the forecast period
Countries like United States and Canada led the Advanced Therapy Medicinal Products Market with the largest market share in 2023 and is expected to maintain its position in the North America region during the forecast period. The market growth is driven by the increasing increasing number of patients and rising health awareness are key factors that are expected to fuel the market in the region.
Instant access is available by downloading your exclusive sample copy of the report right now!
Advanced Therapy Medicinal Products Market Segmentation
By Therapy Type:
- Cell Therapy
- Stem Cell Therapy
- Non-stem Cell Therapy
- CAR-T Therapy
- Gene Therapy
- Tissue Engineered Product
By Disease Type:
- Alzheimer’s
- Cystic Fibrosis
- Muscular Dystrophies
- Haemophilia
By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Advanced Therapy Medicinal Products Market Key Competitors include:
North America Advanced Therapy Medicinal Products Market Key Players:
- Gilead Sciences, Inc. (California, United States)
- Pfizer Inc. (New York, United States)
- Bristol Myers Squibb (New York, United States)
- Johnson & Johnson (New Jersey, United States)
- Merck & Co., Inc. (New Jersey, United States)
- Amgen Inc. (California, United States)
- AbbVie Inc. (North Chicago, United States)
- Biogen Inc. (Massachusetts, United States)
- Eli Lilly and Company (Indiana, United States)
- Regeneron Pharmaceuticals, Inc. (New York, United States)
- Vertex Pharmaceuticals Incorporated (Massachusetts, United States)
- Moderna, Inc. (Massachusetts, United States)
- Bluebird Bio, Inc. (Massachusetts, United States)
- Spark Therapeutics, Inc. (Pennsylvania, United States)
Europe Advanced Therapy Medicinal Products Market Key Players:
- Bayer AG (Leverkusen, Germany)
- Sanofi (Paris, France)
- Novartis AG (Basel, Switzerland)
- AstraZeneca PLC (Cambridge, United Kingdom)
- Roche Holding AG (Basel, Switzerland)
Asia Pacific Advanced Therapy Medicinal Products Market Key Players:
- Takeda Pharmaceutical Company Limited (Tokyo, Japan)
Key questions answered in the Advanced Therapy Medicinal Products Market are:
- What is Advanced Therapy Medicinal Products?
- What is the current growth rate of the Advanced Therapy Medicinal Products Market?
- Who are the key players in the Advanced Therapy Medicinal Products Market?
- What are the factors affecting growth in the Advanced Therapy Medicinal Products Market?
- Who held the largest market share in Advanced Therapy Medicinal Products Market?
- What is the demand pattern for the Advanced Therapy Medicinal Products Market?
- What are the opportunities for the Advanced Therapy Medicinal Products Market?
- What are the strategies used by competitors in the Advanced Therapy Medicinal Products Market?
- What are the growth prospects in developing countries for the Advanced Therapy Medicinal Products Market?
- Which segment is expected to witness the fastest growth and why in the Advanced Therapy Medicinal Products Market?
Key Offerings:
- Past Market Size and Competitive Landscape (2018-2022)
- Past Pricing and price curve by region (2018-2022)
- Market Size, Share, Size & Forecast by different segment | 2023−2030
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
- Market Segmentation – A detailed analysis by Product, Distribution and Region
- Competitive Landscape – Profiles of selected key players by region in a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of business by region
- Lucrative business opportunities with SWOT analysis
- Recommendations
Maximize Market Research is leading “Healthcare” research firm, has also published the following reports:
Bladder Cancer market– The Bladder Cancer Market size was valued at USD 5.95 Billion in 2023 and the total Bladder Cancer Market Size is expected to grow at a CAGR of 4.8% from 2024 to 2030, reaching nearly USD 8.26 Billion by 2030.
Global Hypertrophic Cardiomyopathy Treatment Market– the Global Hypertrophic Cardiomyopathy Treatment Market size was valued at USD 1.31 Billion in 2023 and the total Hypertrophic Cardiomyopathy Treatment revenue is expected to grow at a CAGR of 3.10% from 2024 to 2030, reaching nearly USD 1.62 Billion by 2030.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Media Contact
Company Name: MAXIMIZE MARKET RESEARCH PVT. LTD.
Contact Person: L Godage
Email: Send Email
Phone: +91 9607365656
Address:3rd Floor, Navale IT Park, Phase 2, Pune Banglore Highway, Narhe,
City: Pune
State: Maharashtra
Country: India
Website: https://www.maximizemarketresearch.com/market-report/global-advanced-therapy-medicinal-products-market/119588/